Showing results (981-990 of 26,311) with videos related to

Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Selection of fluorescent biosensors against galectin-3 from an NBD-modified phage library displaying designed α-helical peptidesMasahiro Hashimoto, Takayuki Miki, Iou Ven Chang, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2018
Synthesis and biological activities evaluation of sanjuanolide and its analoguesJiadai Zhai, Lin Fu, Yuanyuan Li, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2021
Identification of a new class of HBV capsid assembly modulatorScott D Kuduk, Bart Stoops, Richard Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2021
Structure, solubility, and permeability relationships in a diverse middle molecule libraryHiroyuki Miyachi, Kayoko Kanamitsu, Mayumi Ishii, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2019
Design, synthesis and biological evaluation of novel serotonin and dopamine receptor ligands being 6-bromohexyl saccharine derivativesDamian Kułaga, Jolanta Jaśkowska, Grzegorz Satała
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasitesManel Ouji, Michel Nguyen, Romain Mustière, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
Synthesis and antibacterial evaluation of new monobactamsZaw Min Thu, Jian Sun, Jingwen Ji, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
1,2,3-Triazole-gold(I)-triethylposphine derivatives active against resistant Gram-positive pathogensMathieu Michaut, Alexandre Steffen, Jean-Marie Contreras, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT2C receptorThomas O Schrader, Xiuwen Zhu, Michelle Kasem, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
Pageof 2,632